Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
The Bank of New York Mellon Corporation ( BK - Analyst Report ) has launched a new Issuer Central Securities Depository (CSD) unit in Europe after receiving the regulatory approval. The CSD unit is aimed at providing the market participants with better trading facilities.
BNY Mellon’s CSD unit, incorporated as a non-banking subsidiary, will be headquartered in Belgium and regulated by the National Bank of Belgium. The unit will provide issuer, settlement and safekeeping services for all the market participants of Europe as well as the worldwide markets. Currently, the company does offer such services to its European clientele; however, on an individual basis.
The establishment of the CSD unit will assist the company in consolidating its operations in the European region. The move follows BNY Mellon’s launch of clearing operations for the customers in Ireland almost a year and a half ago. The unit will be spearheaded by a veteran BNY Mellon executive – Chris Prior-Willeard.
The reason behind the launch of the CSD unit is the changing regulatory landscape, which aims at making the securities market more secure as well as efficient. For BNY Mellon – a bank holding company and one of the world's leading financial institutions – this is an excellent opportunity to enhance investment services.
By establishing the separate CSD unit, in response to the regulatory changes (mainly centered on issuance and settlement services), BNY Mellon expects to offer a plethora of integrated services that would allow market participants to accommodate the new requirements mandated by the European Market Infrastructure Regulation (EMIR) and various other regulatory authorities. Moreover, this unit will connect the European CSD market with the rest of the world and facilitate easy transferability across the globe.
We believe that the CSD wing will be beneficial to both BNY Mellon and the market participants. For the company, it would bring an opportunity to enhance its operations and boost the top-line growth, whereas for the latter, this would mean smoother trading and reduced risks.
Currently, BNY Mellon retains its Zacks #3 Rank, which translates to a short-term Hold rating. However, other stocks in the same sector namely AllianceBernstein Holding L.P. ( AB - Snapshot Report ) and Heartland Financial USA Inc. ( HTLF - Snapshot Report ) carry a Zacks #1 Rank (Strong Buy).
Read the full Analyst Report on BK
Read the full Snapshot Report on AB
Read the full Snapshot Report on HTLF